Vyome Holdings (HIND) Non-Current Deferred Tax Liability (2020 - 2022)
Vyome Holdings (HIND) posted quarterly Non-Current Deferred Tax Liability of $367000.0 for Q2 2022, down 40.33% year-over-year from $615000.0 in Q2 2021, and little changed quarter-over-quarter from $367000.0 in Q1 2022.
Vyome Holdings (HIND) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends
Vyome Holdings' Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $367000.0 for Q2 2022.
- In Q2 2022, Non-Current Deferred Tax Liability fell 40.33% year-over-year to $367000.0; the TTM figure through Jun 2022 stood at $367000.0 (down 40.33% YoY), while the FY2021 annual figure was $367000.0, down 40.33% from the prior year.
- Non-Current Deferred Tax Liability for Q2 2022 stood at $367000.0, roughly flat from $367000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $615000.0 in Q4 2020, with the low at $367000.0 in Q4 2021.
- The 3-year median for Non-Current Deferred Tax Liability is $491000.0 (2020), against an average of $491000.0.
- Peak annual rise in Non-Current Deferred Tax Liability reached 40.33% in 2021, while the deepest fall reached 40.33% in 2021.
- Vyome Holdings' Non-Current Deferred Tax Liability stood at $615000.0 in 2020, then slumped by 40.33% to $367000.0 in 2021, then changed by 0.0% to $367000.0 in 2022.
- Business Quant data shows HIND's Non-Current Deferred Tax Liability at $367000.0 in Q2 2022, $367000.0 in Q1 2022, and $367000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 367,000.00 |
| Jun 30, 2022 | 367,000.00 |
| Mar 31, 2022 | 367,000.00 |
| Mar 31, 2022 | 367,000.00 |
| Dec 31, 2021 | 367,000.00 |
| Dec 31, 2021 | 367,000.00 |
| Sep 30, 2021 | 615,000.00 |
| Sep 30, 2021 | 615,000.00 |
| Jun 30, 2021 | 615,000.00 |
| Jun 30, 2021 | 615,000.00 |
| Dec 31, 2020 | 615,000.00 |
| Dec 31, 2020 | 615,000.00 |